Sensitivity to Escherichia coli Nissle 1917 in mice is dependent on environment and genetic background

International Journal of Experimental Pathology

Volumn 89, Issue 1, 2008, Pages 45-54

  Bleich, Andre ^a   Sundberg, John P ^b   Smoczek, Anna ^a   Von Wasielewski, Reinhard ^a   De Buhr, Maike F ^a   Janus, Lydia M ^a   Julga, Gwen ^a   Ukena, Sya N ^a,c   Hedrich, Hans J ^a   Gunzer, Florian ^a,d  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b JACKSON LABORATORY   (United States)

^c HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^d DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

E. coli Nissle 1917; EcN; Germ free mice; Probiotics

Indexed keywords

PROBIOTIC AGENT; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BACTERIUM; ENVIRONMENTAL FACTOR; ESCHERICHIA COLI NISSLE 1917; GERMFREE ANIMAL; HEREDITY; HISTOLOGY; INFLAMMATION; INOCULATION; INTESTINE EPITHELIUM CELL; MOUSE; NONHUMAN; ORGAN CULTURE; PANCREATITIS; PATHOGENICITY; PHENOTYPE; PRIORITY JOURNAL; PYOGRANULOMATOUS SEROSITIS; TYPHLITIS;

ANIMALS; DISEASE MODELS, ANIMAL; ESCHERICHIA COLI; FEMALE; GERM-FREE LIFE; INTESTINES; MALE; MICE; PROBIOTICS; SENSITIVITY AND SPECIFICITY;

EID: 38049107790     PISSN: 09599673     EISSN: 13652613     Source Type: Journal    
DOI: 10.1111/j.1365-2613.2007.00560.x     Document Type: Article

References (37)

1. Agnese D.M., Calvano J.E., Hahm S.J. et al. (2002) Human toll-like receptor 4 mutations but not CD14 polymorphisms are associated with an increased risk of gram-negative infections. J. Infect. Dis. 186, 1522 1525.
2. Bernheiden M., Heinrich J.M., Minigo G. et al. (2001) LBP, CD14, TLR4 and the murine innate immune response to a peritoneal Salmonella infection. J. Endotoxin. Res. 7, 447 450.
3. Blattner F.R., Plunkett G., 3rd. Bloch C.A. et al. (1997) The complete genome sequence of Escherichia coli K-12. Science 277, 1453 1474.
4. Bleich A. Mähler M. (2005) Environment as a critical factor for the pathogenesis and outcome of gastrointestinal disease: experimental and human inflammatory bowel disease and Helicobacter-induced gastritis. Pathobiology 72, 293 307.
5. Blum-Oehler G., Oswald S., Eiteljorge K. et al. (2003) Development of strain-specific PCR reactions for the detection of the probiotic Escherichia coli strain Nissle 1917 in fecal samples. Res. Microbiol. 154, 59 66.
6. Branger J., Knapp S., Weijer S. et al. (2004) Role of Toll-like receptor 4 in gram-positive and gram-negative pneumonia in mice. Infect. Immun. 72, 788 794.
7. Bristol I.J., Farmer M.A., Cong Y. et al. (2000) Heritable susceptibility for colitis in mice induced by IL-10 deficiency. Inflamm. Bowel Dis. 6, 290 302.
8. Colombel J.F., Cortot A., van Kruiningen H.J. (2001) Antibiotics in Crohn's disease. Gut 48, 647.
9. Cross A.S., Sadoff J.C., Kelly N., Bernton E., Gemski P. (1989) Pretreatment with recombinant murine tumor necrosis factor alpha/cachectin and murine interleukin 1 alpha protects mice from lethal bacterial infection. J. Exp. Med. 169, 2021 2027.
10. Elkahwaji J.E., Ott C.J., Janda L.M., Hopkins W.J. (2005) Mouse model for acute bacterial prostatitis in genetically distinct inbred strains. Urology 66, 883 887.
11. Farmer M.A., Sundberg J.P., Bristol I.J. et al. (2001) A major quantitative trait locus on chromosome 3 controls colitis severity in IL-10-deficient mice. Proc. Natl Acad. Sci. USA 98, 13820 13825.
12. Greenberger M.J., Strieter R.M., Kunkel S.L., Danforth J.M., Goodman R.E., Standiford T.J. (1995) Neutralization of IL-10 increases survival in a murine model of Klebsiella pneumonia. J. Immunol. 155, 722 729.
13. Grozdanov L., Raasch C., Schulze J. et al. (2004) Analysis of the genome structure of the nonpathogenic probiotic Escherichia coli strain Nissle 1917. J. Bacteriol. 186, 5432 5441.
14. Guarner F. Schaafsma G.J. (1998) Probiotics. Int. J. Food Microbiol. 39, 237 238.
15. Hopkins W.J., Gendron-Fitzpatrick A., Balish E., Uehling D.T. (1998) Time course and host responses to Escherichia coli urinary tract infection in genetically distinct mouse strains. Infect. Immun. 66, 2798 2802.
16. Kruis W., Fric P., Pokrotnieks J. et al. (2004) Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine. Gut 53, 1617 1623.
17. Lee J.S., Frevert C.W., Matute-Bello G. et al. (2005) TLR-4 pathway mediates the inflammatory response but not bacterial elimination in E. coli pneumonia. Am. J. Physiol. Lung Cell Mol. Physiol. 289, L731 L738.
18. Mähler M., Most C., Schmidtke S. et al. (2002) Genetics of colitis susceptibility in IL-10-deficient mice: backcross versus F2 results contrasted by principal component analysis. Genomics 80, 274 282.
19. Montes A.H., Asensi V., Alvarez V. et al. (2006) The Toll-like receptor 4 (Asp299Gly) polymorphism is a risk factor for gram-negative and haematogenous osteomyelitis. Clin. Exp. Immunol. 143, 404 413.
20. Nicklas W., Baneux P., Boot R. et al. (2002) Recommendations for the health monitoring of rodent and rabbit colonies in breeding and experimental units. Lab. Anim. 36, 20 42.
21. Nissle A. (1918) Die antagonistische Behandlung chronischer Darmstörungen mit Colibakterien. Med. Klin. 2, 29 30.
22. Poltorak A., He X., Smirnova I. et al. (1998) Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282, 2085 2088.
23. Rembacken B.J., Snelling A.M., Hawkey P.M., Chalmers D.M., Axon A.T. (1999) Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial. Lancet 354, 635 639.
24. Ruiz P.A., Hoffmann M., Szcesny S., Blaut M., Haller D. (2005) Innate mechanisms for Bifidobacterium lactis to activate transient pro-inflammatory host responses in intestinal epithelial cells after the colonization of germ-free rats. Immunology 115, 441 450.
25. Sartor R.B. (2004) Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics. Gastroenterology 126, 1620 1633.
26. Schilling J.D., Mulvey M.A., Vincent C.D., Lorenz R.G., Hultgren S.J. (2001) Bacterial invasion augments epithelial cytokine responses to Escherichia coli through a lipopolysaccharide-dependent mechanism. J. Immunol. 166, 1148 1155.
27. Sellon R.K., Tonkonogy S., Schultz M. et al. (1998) Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infect. Immun. 66, 5224 5231.
28. Shanahan F. (2000) Probiotics and inflammatory bowel disease: is there a scientific rationale? Inflamm. Bowel Dis. 6, 107 115.
29. Shanahan F. (2001) Probiotics in inflamatory bowel disease. Gut 48, 609.
30. Sun J., Gunzer F., Westendorf A.M. et al. (2005) Genomic peculiarity of coding sequences and metabolic potential of probiotic Escherichia coli strain Nissle 1917 inferred from raw genome data. J. Biotechnol. 117, 147 161.
31. Sundberg J.P., Fox J.G., Ward J.M., Bedigian H.G. (1997) Idiopathic focal hepatic necrosis in inbred mice. In : Monographs on Pathology of Laboratory Animals: Digestive System, pp. 213 217 eds T.C. Jones, J.A. Popp, U. Mohr Berlin : Springer-Verlag.
32. Ukena S.N., Westendorf A.M., Hansen W. et al. (2005) The host response to the probiotic Escherichia coli strain Nissle 1917: specific up-regulation of the proinflammatory chemokine MCP-1. BMC. Med. Genet. 6, 43.
33. Vallance B.A., Deng W., Jacobson K., Finlay B.B. (2003) Host susceptibility to the attaching and effacing bacterial pathogen Citrobacter rodentium. Infect. Immun. 71, 3443 3453.
34. Van der Graaf C.A., Netea M.G., Morre S.A. et al. (2006) Toll-like receptor 4 Asp299Gly/Thr399Ile polymorphisms are a risk factor for Candida bloodstream infection. Eur. Cytokine Netw. 17, 29 34.
35. Wang M., Jeng K.C., Ping L.I. (1999) Exogenous cytokine modulation or neutralization of interleukin-10 enhance survival in lipopolysaccharide- hyporesponsive C3H/HeJ mice with Klebsiella infection. Immunology 98, 90 97.
36. Wang X., Moser C., Louboutin J.P. et al. (2002) Toll-like receptor 4 mediates innate immune responses to Haemophilus influenzae infection in mouse lung. J. Immunol. 168, 810 815.
37. Welch R.A., Burland V., Plunkett G., 3rd. et al. (2002) Extensive mosaic structure revealed by the complete genome sequence of uropathogenic Escherichia coli. Proc. Natl Acad. Sci. USA 99, 17020 17024.